$ASTI
Ascent Solar Technologies, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023040015 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $230.0K $101.3K
YoY Change 3524.75% -84.11%
Cost Of Revenue $692.8K $666.3K
YoY Change 69.04% 15.47%
Gross Profit -$462.8K -$565.0K
YoY Change 14.7% -1032.6%
Gross Profit Margin -201.26% -557.71%
Selling, General & Admin $1.407M $1.179M
YoY Change -25.54% 35.21%
% of Gross Profit
Research & Development $344.9K $822.3K
YoY Change -77.6% -43.42%
% of Gross Profit
Depreciation & Amortization $18.93K $19.65K
YoY Change 20.54% 50.62%
% of Gross Profit
Operating Expenses $1.752M $2.001M
YoY Change -48.91% -13.93%
Operating Profit -$2.378M -$3.151M
YoY Change -68.92% 38.07%
Interest Expense -$288.1K -$762.1K
YoY Change 2.88% 2254.19%
% of Operating Profit
Other Income/Expense, Net $468.8K -$761.9K
YoY Change -301.55% 2408.65%
Pretax Income -$1.909M -$3.913M
YoY Change -75.86% 69.21%
Income Tax
% Of Pretax Income
Net Earnings -$1.909M -$3.913M
YoY Change -75.86% 69.21%
Net Earnings / Revenue -830.28% -3863.21%
Basic Earnings Per Share -$4.04 -$0.33
Diluted Earnings Per Share -$4.04 -$0.33
COMMON SHARES
Basic Shares Outstanding 68.94M 49.93M
Diluted Shares Outstanding 473.2K 46.89M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.250M $905.6K
YoY Change -21.07% 110.97%
Cash & Equivalents $2.250M $905.6K
Short-Term Investments
Other Short-Term Assets $258.7K $302.0K
YoY Change -70.44% -62.6%
Inventory $636.0K $678.3K
Prepaid Expenses
Receivables $0.00 $14.92K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.144M $1.901M
YoY Change -30.46% -30.9%
LONG-TERM ASSETS
Property, Plant & Equipment $4.057M $4.352M
YoY Change 657.27% 713.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $65.78K $67.69K
YoY Change 7.39% -25.95%
Other Assets $1.328M $1.332M
YoY Change 112.41% 113.2%
Total Long-Term Assets $8.012M $9.761M
YoY Change 38.33% 62.66%
TOTAL ASSETS
Total Short-Term Assets $3.144M $1.901M
Total Long-Term Assets $8.012M $9.761M
Total Assets $11.16M $11.66M
YoY Change 8.17% 33.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.301M $1.152M
YoY Change 81.41% 39.21%
Accrued Expenses $984.6K $783.3K
YoY Change -57.95% -48.16%
Deferred Revenue
YoY Change
Short-Term Debt $6.721M $750.4K
YoY Change 2588.22% 200.15%
Long-Term Debt Due $319.5K $5.606M
YoY Change
Total Short-Term Liabilities $11.87M $11.02M
YoY Change 159.09% 187.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $2.193M $3.433M
YoY Change -45.54% -18.46%
Total Long-Term Liabilities $2.193M $3.433M
YoY Change -45.54% -33.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.87M $11.02M
Total Long-Term Liabilities $2.193M $3.433M
Total Liabilities $14.06M $14.45M
YoY Change 63.39% 60.45%
SHAREHOLDERS EQUITY
Retained Earnings -$471.0M -$469.1M
YoY Change 6.49% 7.98%
Common Stock $55.00 $5.566K
YoY Change -98.38% 81.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.907M -$2.793M
YoY Change
Total Liabilities & Shareholders Equity $11.16M $11.66M
YoY Change 8.17% 33.25%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.909M -$3.913M
YoY Change -75.86% 69.21%
Depreciation, Depletion And Amortization $18.93K $19.65K
YoY Change 20.54% 50.62%
Cash From Operating Activities -$749.4K -$1.640M
YoY Change -70.61% -36.51%
INVESTING ACTIVITIES
Capital Expenditures $13.96K $3.795M
YoY Change -149.7% -44228.02%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$13.96K -$3.795M
YoY Change -51.7% 24415.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.093M 1.750K
YoY Change -58.14%
NET CHANGE
Cash From Operating Activities -749.4K -1.640M
Cash From Investing Activities -13.96K -3.795M
Cash From Financing Activities 2.093M 1.750K
Net Change In Cash 1.330M -5.433M
YoY Change -45.08% 109.05%
FREE CASH FLOW
Cash From Operating Activities -$749.4K -$1.640M
Capital Expenditures $13.96K $3.795M
Free Cash Flow -$763.4K -$5.435M
YoY Change -69.73% 111.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001350102
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
78567
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32919
dei Entity Registrant Name
EntityRegistrantName
Ascent Solar Technologies, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3672603
dei Entity Address Address Line1
EntityAddressAddressLine1
12300 Grant Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Thornton
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80241
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
872-5000
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
ASTI
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68937658
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
905621
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11483018
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14916
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1769
CY2023Q2 us-gaap Inventory Net
InventoryNet
678288
CY2022Q4 us-gaap Inventory Net
InventoryNet
615283
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
302044
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
344110
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1900869
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12444180
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26431542
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22590169
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22079147
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22038508
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4352395
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
551661
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3929876
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4324514
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
163803
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
154218
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79983
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
67685
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
61379
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1332471
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1214985
CY2023Q2 us-gaap Other Assets
OtherAssets
5408599
CY2022Q4 us-gaap Other Assets
OtherAssets
5680861
CY2023Q2 us-gaap Assets
Assets
11661863
CY2022Q4 us-gaap Assets
Assets
18676702
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1152303
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
595157
CY2023Q2 asti Related Party Payables Current
RelatedPartyPayablesCurrent
15193
CY2022Q4 asti Related Party Payables Current
RelatedPartyPayablesCurrent
67164
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
783276
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
888869
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
491895
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
927264
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
784551
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
952573
CY2023Q2 asti Accrued Interest Current
AccruedInterestCurrent
672969
CY2022Q4 asti Accrued Interest Current
AccruedInterestCurrent
559060
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
765378
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
733572
CY2023Q2 asti Conversions Payable Current
ConversionsPayableCurrent
500370
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
5606467
CY2023Q2 asti Note Payable Excluding Convertible Note Current
NotePayableExcludingConvertibleNoteCurrent
250000
CY2022Q4 asti Note Payable Excluding Convertible Note Current
NotePayableExcludingConvertibleNoteCurrent
250000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11022402
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4973659
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3411364
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3827878
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5268399
CY2023Q2 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
21225
CY2022Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
21225
CY2023Q2 us-gaap Liabilities
Liabilities
14454991
CY2022Q4 us-gaap Liabilities
Liabilities
14091161
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
5
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
5
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55937658
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55937658
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34000812
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34000812
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5566
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3400
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
466294127
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
452135653
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-469078672
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447537493
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14154
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16024
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2793128
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4585541
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11661863
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18676702
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
101301
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
637571
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225526
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1203781
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
666269
CY2022Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
576994
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1128064
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1109885
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
822321
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1453273
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2488016
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2859595
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1178832
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
871881
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2770652
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1693145
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
560861
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1965311
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24443
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17838
us-gaap Depreciation And Amortization
DepreciationAndAmortization
50224
us-gaap Depreciation And Amortization
DepreciationAndAmortization
34503
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
3252726
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
2919986
us-gaap Costs And Expenses
CostsAndExpenses
8402267
us-gaap Costs And Expenses
CostsAndExpenses
5697128
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3151425
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2282415
us-gaap Operating Income Loss
OperatingIncomeLoss
-8176741
us-gaap Operating Income Loss
OperatingIncomeLoss
-4493347
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2023Q2 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
761877
CY2022Q2 asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
32370
asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
1829913
asti Interest Expense Excluding Warrant Liability
InterestExpenseExcludingWarrantLiability
2118685
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-761877
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30370
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1819913
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2116685
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-170
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-170
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3913472
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2312785
us-gaap Net Income Loss
NetIncomeLoss
-9996824
us-gaap Net Income Loss
NetIncomeLoss
-6610034
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46887774
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30587415
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41208236
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26154266
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46887774
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30587415
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41208236
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26154266
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4836
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6256
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1870
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-13353
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3918308
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2319041
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9994954
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6623387
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4585541
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1404450
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6083352
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
6706
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2180440
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
560861
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
900000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
20000
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
92750
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3913472
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145423
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4606
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10577397
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-4836
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2793128
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2833606
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4297249
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-7097
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2062048
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2312785
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-6256
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-256993
us-gaap Net Income Loss
NetIncomeLoss
-9996824
us-gaap Net Income Loss
NetIncomeLoss
-6610034
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50224
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34503
us-gaap Share Based Compensation
ShareBasedCompensation
1965311
asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
394638
asti Operating Lease Asset Amortization
OperatingLeaseAssetAmortization
340114
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1542085
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2086301
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-170
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2
asti Adjustments To Inventory Reserve Expense
AdjustmentsToInventoryReserveExpense
83357
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13147
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
786824
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146362
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85934
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-17330
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
559774
asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
557146
asti Increase Decrease In Accounts Payable Excluding Related Party
IncreaseDecreaseInAccountsPayableExcludingRelatedParty
185596
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-51971
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
7127
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-384708
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-322729
asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
113909
asti Increase Decrease In Accrued Interest Payable
IncreaseDecreaseInAccruedInterestPayable
30383
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-708984
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
305585
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6577826
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5375684
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
83559
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3841373
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
66053
asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
-8169
asti Proceeds From Payments To Patent Activity
ProceedsFromPaymentsToPatentActivity
-7192
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3849542
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-156804
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
880000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1025423
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5532488
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11483018
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5961760
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
905621
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
429272
asti Right Of Use Assets Acquired Through Operating Lease Liabilities
RightOfUseAssetsAcquiredThroughOperatingLeaseLiabilities
21045
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
213922
asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
3364467
asti Conversion Of Stock To Equity Amount
ConversionOfStockToEquityAmount
9200000
asti Series One A Preferred Stock Conversion
SeriesOneAPreferredStockConversion
740
asti Down Round Deened Dividend
DownRoundDeenedDividend
11653986
us-gaap Interest Paid Net
InterestPaidNet
173600
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14916
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1769
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
13000
asti Additions Of Deferred Revenue
AdditionsOfDeferredRevenue
29350
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-29350
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
13000
us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
11653986
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
55300000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3913472
us-gaap Net Income Loss
NetIncomeLoss
-9996824
CY2023Q2 asti Down Round Deemed Dividend
DownRoundDeemedDividend
-11653986
asti Down Round Deemed Dividend
DownRoundDeemedDividend
-11653986
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15567458
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21650810
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6577826
CY2023Q2 asti Working Capital Deficit
WorkingCapitalDeficit
9121533
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26431542
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22590169
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22079147
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22038508
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4352395
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
551661
CY2023Q2 us-gaap Depreciation
Depreciation
19650
CY2022Q2 us-gaap Depreciation
Depreciation
13046
us-gaap Depreciation
Depreciation
40639
us-gaap Depreciation
Depreciation
24919
asti Number Of Rentable Square Feet Of Building
NumberOfRentableSquareFeetOfBuilding
100000
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
This lease is classified and accounted for as an operating lease. The building lease term is for 88 months commencing on September 21, 2020 at a rent of $50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $80,000 per month on a triple net basis and shall increase at an annual rate of 3% per annum until December 31, 2027.
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P88M
CY2020Q3 asti Lease Commencement Date
LeaseCommencementDate
2020-09-21
CY2020Q3 us-gaap Lease Cost
LeaseCost
50000
CY2021Q1 us-gaap Lease Cost
LeaseCost
80000
asti Percentage Of Rent Increase In Annual Rate
PercentageOfRentIncreaseInAnnualRate
0.03
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3929876
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4324514
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
765378
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
733572
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3411364
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3827878
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
271542
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
258392
us-gaap Operating Lease Cost
OperatingLeaseCost
533910
us-gaap Operating Lease Cost
OperatingLeaseCost
516785
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
509232
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1049018
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1080488
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1112903
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1146290
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4897931
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
721189
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4176742
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P54M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
598160
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
577799
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
17701
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
37351
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
62427
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
133
CY2023Q2 us-gaap Inventory Net
InventoryNet
678288
CY2022Q4 us-gaap Inventory Net
InventoryNet
615283
CY2022Q4 asti Debt Current And Noncurrent
DebtCurrentAndNoncurrent
14892899
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7274540
CY2023Q2 asti Debt Current And Noncurrent
DebtCurrentAndNoncurrent
7618359
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2011892
CY2023Q2 asti Convertible Notes Payable Current And Noncurrent
ConvertibleNotesPayableCurrentAndNoncurrent
5606467
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
2000000
CY2023Q2 asti Adjustments To Down Round Deemed Dividend
AdjustmentsToDownRoundDeemedDividend
11653986
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7300000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3364467
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
500370
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1025423
asti Accelerated Discount Recognized In Apic
AcceleratedDiscountRecognizedInAPIC
2384280
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7274540
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
asti Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55937658
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
7300000
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
21651846
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
285000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
79314823
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3152033
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
407519
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
2277848
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
5.37
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
466666
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.98

Files In Submission

Name View Source Status
0000950170-23-040015-index-headers.html Edgar Link pending
0000950170-23-040015-index.html Edgar Link pending
0000950170-23-040015.txt Edgar Link pending
0000950170-23-040015-xbrl.zip Edgar Link pending
asti-20230630.htm Edgar Link pending
asti-20230630.xsd Edgar Link pending
asti-ex31_1.htm Edgar Link pending
asti-ex31_2.htm Edgar Link pending
asti-ex32_1.htm Edgar Link pending
asti-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
asti-20230630_cal.xml Edgar Link unprocessable
asti-20230630_pre.xml Edgar Link unprocessable
asti-20230630_lab.xml Edgar Link unprocessable
asti-20230630_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
asti-20230630_def.xml Edgar Link unprocessable